Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 54 | 2024 | 16718 | 1.740 |
Why?
|
Herpes Genitalis | 3 | 2012 | 141 | 1.030 |
Why?
|
CD4-Positive T-Lymphocytes | 16 | 2022 | 4386 | 0.900 |
Why?
|
Ribonucleotides | 3 | 2019 | 117 | 0.760 |
Why?
|
Deoxyribonucleotides | 2 | 2019 | 42 | 0.750 |
Why?
|
HIV-1 | 22 | 2021 | 6939 | 0.750 |
Why?
|
Dideoxynucleotides | 1 | 2019 | 13 | 0.730 |
Why?
|
Leukocytes, Mononuclear | 5 | 2021 | 1836 | 0.680 |
Why?
|
Acquired Immunodeficiency Syndrome | 8 | 2023 | 2232 | 0.650 |
Why?
|
CD4 Lymphocyte Count | 8 | 2020 | 2559 | 0.630 |
Why?
|
Antiretroviral Therapy, Highly Active | 8 | 2023 | 1873 | 0.630 |
Why?
|
Biostatistics | 1 | 2019 | 162 | 0.610 |
Why?
|
Anti-HIV Agents | 9 | 2023 | 4256 | 0.600 |
Why?
|
Herpesvirus 2, Human | 3 | 2012 | 189 | 0.540 |
Why?
|
Sexually Transmitted Diseases | 3 | 2009 | 624 | 0.510 |
Why?
|
ROC Curve | 2 | 2020 | 3527 | 0.500 |
Why?
|
Viral Load | 15 | 2023 | 3299 | 0.490 |
Why?
|
Anti-Retroviral Agents | 6 | 2023 | 1715 | 0.480 |
Why?
|
Risk-Taking | 2 | 2009 | 986 | 0.460 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2022 | 4479 | 0.430 |
Why?
|
Sexual Behavior | 6 | 2024 | 2057 | 0.410 |
Why?
|
HIV | 7 | 2016 | 1604 | 0.380 |
Why?
|
Tuberculosis | 3 | 2020 | 1912 | 0.370 |
Why?
|
Tuberculosis, Meningeal | 2 | 2021 | 45 | 0.370 |
Why?
|
Alcoholism | 3 | 2009 | 1906 | 0.360 |
Why?
|
Killer Cells, Natural | 8 | 2018 | 2133 | 0.350 |
Why?
|
Sexual Partners | 5 | 2023 | 730 | 0.340 |
Why?
|
Central Nervous System Infections | 2 | 2023 | 56 | 0.340 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2020 | 1821 | 0.340 |
Why?
|
Coitus | 1 | 2009 | 133 | 0.330 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 4 | 2019 | 222 | 0.320 |
Why?
|
AIDS Vaccines | 4 | 2019 | 938 | 0.310 |
Why?
|
HIV Antibodies | 5 | 2018 | 1322 | 0.310 |
Why?
|
Receptors, Fc | 3 | 2018 | 541 | 0.300 |
Why?
|
Vagina | 5 | 2022 | 825 | 0.290 |
Why?
|
Epidemics | 1 | 2012 | 523 | 0.280 |
Why?
|
Tanzania | 4 | 2012 | 1346 | 0.260 |
Why?
|
Apoptosis | 7 | 2021 | 9727 | 0.260 |
Why?
|
Lactobacillus | 4 | 2022 | 189 | 0.250 |
Why?
|
Models, Statistical | 1 | 2019 | 5102 | 0.240 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2020 | 657 | 0.240 |
Why?
|
HLA-B Antigens | 3 | 2019 | 353 | 0.230 |
Why?
|
Receptors, KIR | 6 | 2016 | 113 | 0.230 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2022 | 1366 | 0.220 |
Why?
|
Lymphocyte Subsets | 2 | 2016 | 315 | 0.220 |
Why?
|
Mycobacterium tuberculosis | 5 | 2019 | 1832 | 0.220 |
Why?
|
Immunization, Passive | 2 | 2016 | 623 | 0.220 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2886 | 0.210 |
Why?
|
Humans | 97 | 2024 | 744343 | 0.210 |
Why?
|
Epitopes | 3 | 2022 | 2571 | 0.200 |
Why?
|
B-Lymphocyte Subsets | 1 | 2023 | 246 | 0.200 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2021 | 2988 | 0.200 |
Why?
|
Head and Neck Neoplasms | 5 | 2014 | 2734 | 0.200 |
Why?
|
Heterosexuality | 1 | 2023 | 276 | 0.200 |
Why?
|
Ghana | 2 | 2020 | 286 | 0.200 |
Why?
|
Homosexuality, Male | 3 | 2024 | 1240 | 0.190 |
Why?
|
Epoxide Hydrolases | 1 | 2021 | 122 | 0.190 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2018 | 1369 | 0.190 |
Why?
|
Vaginosis, Bacterial | 1 | 2022 | 128 | 0.190 |
Why?
|
HLA-C Antigens | 3 | 2016 | 147 | 0.190 |
Why?
|
Viremia | 3 | 2019 | 736 | 0.180 |
Why?
|
Immunity, Humoral | 2 | 2016 | 598 | 0.170 |
Why?
|
Immunoglobulin G | 5 | 2020 | 4560 | 0.170 |
Why?
|
Zambia | 4 | 2023 | 261 | 0.170 |
Why?
|
Female | 57 | 2023 | 380194 | 0.170 |
Why?
|
Premature Birth | 2 | 2021 | 1721 | 0.170 |
Why?
|
Host-Pathogen Interactions | 3 | 2019 | 1477 | 0.170 |
Why?
|
Awards and Prizes | 1 | 2023 | 375 | 0.170 |
Why?
|
Influenza A virus | 1 | 2022 | 456 | 0.160 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1978 | 0.160 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 427 | 0.160 |
Why?
|
HIV Core Protein p24 | 1 | 2018 | 256 | 0.160 |
Why?
|
Genotype | 5 | 2021 | 12951 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 805 | 0.160 |
Why?
|
Taxoids | 2 | 2013 | 666 | 0.160 |
Why?
|
Interleukin-10 | 2 | 2014 | 1200 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 570 | 0.150 |
Why?
|
Antigens, CD | 4 | 2020 | 4026 | 0.150 |
Why?
|
Simian immunodeficiency virus | 2 | 2014 | 846 | 0.150 |
Why?
|
Male | 48 | 2024 | 350118 | 0.150 |
Why?
|
Autoantigens | 2 | 2020 | 892 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 602 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2021 | 21746 | 0.140 |
Why?
|
Adult | 38 | 2023 | 214055 | 0.140 |
Why?
|
Latent Tuberculosis | 2 | 2016 | 225 | 0.140 |
Why?
|
Neoplasm Metastasis | 5 | 2014 | 4851 | 0.140 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 323 | 0.140 |
Why?
|
Depressive Disorder | 1 | 2009 | 3748 | 0.140 |
Why?
|
Carcinoma, Lobular | 1 | 2020 | 484 | 0.140 |
Why?
|
Alleles | 3 | 2022 | 6933 | 0.140 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2016 | 279 | 0.130 |
Why?
|
Phagocytosis | 3 | 2018 | 1539 | 0.130 |
Why?
|
Immunoassay | 1 | 2019 | 752 | 0.130 |
Why?
|
South Africa | 6 | 2017 | 1731 | 0.130 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2011 | 570 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 880 | 0.130 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13989 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6538 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2022 | 738 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2020 | 806 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 135 | 0.120 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 112 | 0.120 |
Why?
|
Tourette Syndrome | 2 | 2007 | 379 | 0.120 |
Why?
|
Mitochondria | 3 | 2017 | 3520 | 0.120 |
Why?
|
Progestins | 1 | 2015 | 306 | 0.120 |
Why?
|
Young Adult | 15 | 2021 | 56430 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2021 | 2309 | 0.110 |
Why?
|
Herpesviridae | 1 | 2014 | 109 | 0.110 |
Why?
|
Macrophages | 3 | 2018 | 5655 | 0.110 |
Why?
|
Lymphocyte Activation | 5 | 2016 | 5524 | 0.110 |
Why?
|
Algorithms | 3 | 2021 | 13881 | 0.110 |
Why?
|
Cervix Uteri | 1 | 2017 | 590 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1004 | 0.110 |
Why?
|
Prevalence | 5 | 2021 | 15226 | 0.110 |
Why?
|
Bereavement | 2 | 2006 | 277 | 0.110 |
Why?
|
Bacteria | 3 | 2024 | 2114 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 3 | 2013 | 3143 | 0.100 |
Why?
|
Viruses | 1 | 2016 | 374 | 0.100 |
Why?
|
Middle Aged | 30 | 2023 | 213383 | 0.100 |
Why?
|
DNA Fingerprinting | 1 | 2011 | 112 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2216 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2035 | 0.100 |
Why?
|
Nucleotides | 1 | 2014 | 464 | 0.100 |
Why?
|
Dendritic Cells | 2 | 2014 | 2725 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2019 | 10180 | 0.100 |
Why?
|
Carboplatin | 1 | 2014 | 801 | 0.100 |
Why?
|
Alphapapillomavirus | 1 | 2014 | 221 | 0.100 |
Why?
|
Antigen Presentation | 2 | 2014 | 1284 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 11524 | 0.100 |
Why?
|
Stavudine | 1 | 2010 | 85 | 0.100 |
Why?
|
Parental Consent | 1 | 2011 | 62 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2013 | 4034 | 0.090 |
Why?
|
Kidney Neoplasms | 3 | 2013 | 4262 | 0.090 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2014 | 615 | 0.090 |
Why?
|
Flow Cytometry | 7 | 2017 | 5974 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1470 | 0.090 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2010 | 57 | 0.090 |
Why?
|
Nucleosides | 1 | 2010 | 138 | 0.090 |
Why?
|
Carbonic Anhydrases | 1 | 2010 | 115 | 0.090 |
Why?
|
Genetic Research | 1 | 2011 | 174 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 2 | 2016 | 1838 | 0.090 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3176 | 0.090 |
Why?
|
Immunity, Innate | 5 | 2016 | 2958 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2022 | 20822 | 0.090 |
Why?
|
Acidosis, Lactic | 1 | 2011 | 142 | 0.090 |
Why?
|
Disease Progression | 6 | 2016 | 13284 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1632 | 0.090 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 3 | 2018 | 307 | 0.090 |
Why?
|
Protein Isoforms | 2 | 2011 | 1730 | 0.090 |
Why?
|
Lamivudine | 1 | 2010 | 342 | 0.090 |
Why?
|
Phagocytes | 1 | 2011 | 297 | 0.090 |
Why?
|
Adenoma, Oxyphilic | 1 | 2010 | 143 | 0.090 |
Why?
|
Mucous Membrane | 3 | 2021 | 673 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4665 | 0.080 |
Why?
|
Zidovudine | 1 | 2010 | 620 | 0.080 |
Why?
|
Levamisole | 1 | 2008 | 35 | 0.080 |
Why?
|
Hepatitis C, Chronic | 2 | 2014 | 1031 | 0.080 |
Why?
|
Granzymes | 1 | 2010 | 271 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2133 | 0.080 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2011 | 252 | 0.080 |
Why?
|
Colorectal Neoplasms | 1 | 2008 | 6773 | 0.080 |
Why?
|
Cross-Sectional Studies | 7 | 2021 | 25043 | 0.080 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 3 | 2014 | 27 | 0.080 |
Why?
|
Adaptation, Psychological | 3 | 2008 | 2576 | 0.080 |
Why?
|
Immune Evasion | 1 | 2011 | 360 | 0.080 |
Why?
|
Virus Diseases | 1 | 2014 | 711 | 0.080 |
Why?
|
Hyperplasia | 2 | 2021 | 1185 | 0.080 |
Why?
|
Age Factors | 4 | 2013 | 18370 | 0.080 |
Why?
|
Lymphocyte Count | 4 | 2012 | 793 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2020 | 3479 | 0.070 |
Why?
|
Truth Disclosure | 1 | 2011 | 436 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
Paclitaxel | 1 | 2014 | 1708 | 0.070 |
Why?
|
Antigens, Differentiation | 1 | 2010 | 927 | 0.070 |
Why?
|
SAIDS Vaccines | 1 | 2008 | 166 | 0.070 |
Why?
|
Neonatal Screening | 1 | 2011 | 591 | 0.070 |
Why?
|
Vaccines, DNA | 1 | 2008 | 305 | 0.070 |
Why?
|
Camptothecin | 1 | 2009 | 576 | 0.070 |
Why?
|
Immunophenotyping | 3 | 2016 | 1880 | 0.070 |
Why?
|
Minority Groups | 2 | 2023 | 1223 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 460 | 0.070 |
Why?
|
Lactic Acid | 1 | 2011 | 1133 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2014 | 1401 | 0.070 |
Why?
|
Child Abuse, Sexual | 1 | 2008 | 383 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 783 | 0.060 |
Why?
|
Fatigue | 3 | 2022 | 1531 | 0.060 |
Why?
|
Quinolines | 1 | 2010 | 732 | 0.060 |
Why?
|
Receptors, CCR5 | 2 | 2021 | 497 | 0.060 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2016 | 370 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15540 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2596 | 0.060 |
Why?
|
Fibrosis | 2 | 2023 | 2029 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 12072 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2020 | 63114 | 0.060 |
Why?
|
Sample Size | 1 | 2008 | 845 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 8987 | 0.060 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2021 | 310 | 0.060 |
Why?
|
Substance Abuse, Intravenous | 1 | 2009 | 525 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4838 | 0.060 |
Why?
|
Urban Population | 1 | 2012 | 2021 | 0.060 |
Why?
|
Chemotaxis | 2 | 2021 | 607 | 0.060 |
Why?
|
Viral Proteins | 1 | 2011 | 1900 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1364 | 0.060 |
Why?
|
Imidazoles | 1 | 2010 | 1206 | 0.060 |
Why?
|
Cell Degranulation | 2 | 2018 | 287 | 0.060 |
Why?
|
Placebos | 1 | 2008 | 1676 | 0.060 |
Why?
|
Risk Factors | 6 | 2021 | 72290 | 0.060 |
Why?
|
Virus Replication | 3 | 2019 | 2534 | 0.060 |
Why?
|
Immunoglobulin D | 1 | 2023 | 56 | 0.060 |
Why?
|
Fluorouracil | 1 | 2008 | 1619 | 0.060 |
Why?
|
Receptors, CXCR5 | 1 | 2023 | 92 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18029 | 0.050 |
Why?
|
DNA, Viral | 2 | 2023 | 2225 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 2 | 2014 | 82 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1564 | 0.050 |
Why?
|
Psychotherapy, Group | 1 | 2006 | 406 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2011 | 3474 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2014 | 91 | 0.050 |
Why?
|
DNA | 2 | 2014 | 7301 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 1988 | 0.050 |
Why?
|
Vaccination | 1 | 2014 | 3278 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2539 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2971 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2014 | 6895 | 0.050 |
Why?
|
Breast | 2 | 2021 | 1969 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12245 | 0.050 |
Why?
|
Medication Adherence | 2 | 2023 | 2063 | 0.050 |
Why?
|
Aged | 15 | 2021 | 163280 | 0.050 |
Why?
|
Interleukin-2 | 3 | 2015 | 1904 | 0.050 |
Why?
|
Interferon-gamma | 3 | 2016 | 3206 | 0.050 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 157 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1348 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2021 | 209 | 0.050 |
Why?
|
Cell Death | 3 | 2011 | 1706 | 0.050 |
Why?
|
Metronidazole | 1 | 2022 | 217 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 2872 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7785 | 0.050 |
Why?
|
HIV Seropositivity | 1 | 2006 | 971 | 0.050 |
Why?
|
Macaca mulatta | 3 | 2014 | 2375 | 0.050 |
Why?
|
Receptors, CXCR3 | 1 | 2021 | 237 | 0.050 |
Why?
|
Chemokine CXCL10 | 1 | 2021 | 304 | 0.050 |
Why?
|
Polypharmacy | 1 | 2023 | 294 | 0.050 |
Why?
|
DNA, Mitochondrial | 2 | 2017 | 817 | 0.050 |
Why?
|
Antibody Specificity | 2 | 2014 | 1095 | 0.050 |
Why?
|
Hepatitis C | 1 | 2010 | 1591 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3036 | 0.050 |
Why?
|
Social Behavior | 1 | 2007 | 1127 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2021 | 249 | 0.040 |
Why?
|
Cohort Studies | 7 | 2018 | 40561 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2013 | 4933 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3479 | 0.040 |
Why?
|
Caregivers | 1 | 2011 | 2094 | 0.040 |
Why?
|
Reagent Strips | 1 | 2019 | 39 | 0.040 |
Why?
|
United States | 6 | 2023 | 69872 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 768 | 0.040 |
Why?
|
Administration, Intranasal | 2 | 2013 | 446 | 0.040 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2019 | 88 | 0.040 |
Why?
|
Child, Preschool | 2 | 2020 | 41006 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3798 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6365 | 0.040 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2016 | 952 | 0.040 |
Why?
|
Survival Analysis | 2 | 2011 | 10252 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7474 | 0.040 |
Why?
|
Child | 6 | 2020 | 77709 | 0.040 |
Why?
|
Population Surveillance | 1 | 2009 | 2616 | 0.040 |
Why?
|
5'-Nucleotidase | 1 | 2019 | 160 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1041 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2020 | 645 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 434 | 0.040 |
Why?
|
Insulin | 1 | 2013 | 6580 | 0.040 |
Why?
|
Inflammation | 3 | 2023 | 10638 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 889 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 973 | 0.040 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2007 | 1444 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2006 | 2258 | 0.040 |
Why?
|
Adolescent | 10 | 2016 | 85781 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 874 | 0.040 |
Why?
|
Time Factors | 7 | 2015 | 40075 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 79 | 0.040 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 68 | 0.040 |
Why?
|
Animals | 10 | 2022 | 168757 | 0.040 |
Why?
|
Cytochromes c | 1 | 2017 | 180 | 0.040 |
Why?
|
Mice | 6 | 2022 | 81183 | 0.040 |
Why?
|
HIV Enteropathy | 1 | 2016 | 6 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2016 | 87 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2009 | 3966 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2017 | 264 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1357 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2019 | 611 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2016 | 184 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1202 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2540 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6770 | 0.030 |
Why?
|
Lectins, C-Type | 2 | 2010 | 588 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19229 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.030 |
Why?
|
RNA, Viral | 2 | 2015 | 2902 | 0.030 |
Why?
|
Genetic Variation | 3 | 2016 | 6544 | 0.030 |
Why?
|
Acute Disease | 2 | 2019 | 7149 | 0.030 |
Why?
|
Immunization | 1 | 2019 | 1256 | 0.030 |
Why?
|
Down-Regulation | 2 | 2014 | 3002 | 0.030 |
Why?
|
Schools | 1 | 2023 | 1433 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 411 | 0.030 |
Why?
|
Nucleotide Transport Proteins | 1 | 2014 | 3 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2015 | 256 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6171 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2021 | 25625 | 0.030 |
Why?
|
Cryptococcus | 1 | 2014 | 29 | 0.030 |
Why?
|
Schizophrenia | 1 | 2013 | 6882 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.030 |
Why?
|
Grief | 2 | 2006 | 247 | 0.030 |
Why?
|
Perforin | 1 | 2014 | 168 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2021 | 1613 | 0.030 |
Why?
|
JC Virus | 1 | 2014 | 85 | 0.030 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 109 | 0.030 |
Why?
|
Toxoplasmosis | 1 | 2014 | 91 | 0.030 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2015 | 314 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2013 | 173 | 0.030 |
Why?
|
Students | 1 | 2023 | 1654 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 77449 | 0.030 |
Why?
|
Biological Evolution | 1 | 2019 | 1076 | 0.030 |
Why?
|
Pancreas | 1 | 2020 | 1686 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2016 | 558 | 0.030 |
Why?
|
Cryptococcosis | 1 | 2014 | 101 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 551 | 0.030 |
Why?
|
DNA, Protozoan | 1 | 2014 | 237 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1126 | 0.030 |
Why?
|
Africa | 1 | 2015 | 673 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2016 | 582 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2014 | 898 | 0.030 |
Why?
|
Toxoplasma | 1 | 2014 | 150 | 0.030 |
Why?
|
Pregnancy | 3 | 2021 | 29144 | 0.030 |
Why?
|
DNA, Fungal | 1 | 2014 | 280 | 0.030 |
Why?
|
Injections | 1 | 2015 | 840 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 557 | 0.030 |
Why?
|
Leukopenia | 1 | 2013 | 212 | 0.030 |
Why?
|
Biodiversity | 1 | 2015 | 341 | 0.030 |
Why?
|
Genome, Viral | 1 | 2016 | 667 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7913 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2009 | 7880 | 0.030 |
Why?
|
Contraception | 1 | 2015 | 359 | 0.030 |
Why?
|
Prostate | 1 | 2020 | 1774 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9438 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2013 | 4328 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2017 | 1157 | 0.030 |
Why?
|
Receptors, Interleukin-8A | 1 | 2011 | 44 | 0.030 |
Why?
|
Demography | 2 | 2007 | 1656 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2007 | 4245 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2021 | 3200 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2015 | 954 | 0.020 |
Why?
|
Survivors | 1 | 2022 | 2291 | 0.020 |
Why?
|
Cryopreservation | 1 | 2016 | 670 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2010 | 11 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 634 | 0.020 |
Why?
|
Lymphopenia | 1 | 2013 | 285 | 0.020 |
Why?
|
Deoxycytidine Kinase | 1 | 2010 | 12 | 0.020 |
Why?
|
Uganda | 1 | 2016 | 1243 | 0.020 |
Why?
|
Polyphosphates | 1 | 2010 | 18 | 0.020 |
Why?
|
Cytosol | 1 | 2014 | 901 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 914 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2107 | 0.020 |
Why?
|
Prospective Studies | 4 | 2019 | 53288 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2014 | 592 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2011 | 231 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2716 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2011 | 126 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2014 | 486 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.020 |
Why?
|
Public Opinion | 1 | 2014 | 477 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14722 | 0.020 |
Why?
|
Receptors, KIR2DL1 | 1 | 2010 | 15 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2014 | 560 | 0.020 |
Why?
|
Recurrence | 2 | 2014 | 8340 | 0.020 |
Why?
|
Gene Expression | 2 | 2016 | 7799 | 0.020 |
Why?
|
Cytokines | 2 | 2016 | 7322 | 0.020 |
Why?
|
Ethics, Clinical | 1 | 2011 | 101 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2014 | 635 | 0.020 |
Why?
|
Blood Banks | 1 | 2011 | 111 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 455 | 0.020 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 197 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2011 | 337 | 0.020 |
Why?
|
Interleukins | 1 | 2015 | 791 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 2010 | 290 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2015 | 4420 | 0.020 |
Why?
|
Mammography | 1 | 2021 | 2476 | 0.020 |
Why?
|
Trust | 1 | 2014 | 505 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2010 | 71 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2014 | 1663 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2779 | 0.020 |
Why?
|
Myristic Acids | 1 | 2009 | 48 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2014 | 3690 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2010 | 211 | 0.020 |
Why?
|
Polysaccharides | 1 | 2016 | 1053 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.020 |
Why?
|
Cell Fusion | 1 | 2010 | 297 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3588 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1252 | 0.020 |
Why?
|
Cell Movement | 2 | 2011 | 5217 | 0.020 |
Why?
|
Glucuronosyltransferase | 1 | 2009 | 128 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1799 | 0.020 |
Why?
|
K562 Cells | 1 | 2010 | 634 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2014 | 1465 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12354 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2015 | 899 | 0.020 |
Why?
|
Blood Donors | 1 | 2011 | 355 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 578 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1791 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2274 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2803 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2014 | 714 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1434 | 0.020 |
Why?
|
Point Mutation | 1 | 2013 | 1623 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2011 | 669 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1338 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1607 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1060 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6473 | 0.020 |
Why?
|
Hypotension | 1 | 2013 | 884 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1799 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1940 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4397 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.020 |
Why?
|
Transcription Factors | 2 | 2021 | 12208 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2009 | 611 | 0.020 |
Why?
|
Wisconsin | 1 | 2006 | 124 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4986 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2740 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 552 | 0.020 |
Why?
|
Chronic Disease | 2 | 2012 | 9146 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2011 | 1179 | 0.020 |
Why?
|
Boronic Acids | 1 | 2011 | 965 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1356 | 0.020 |
Why?
|
Family Characteristics | 1 | 2011 | 1000 | 0.020 |
Why?
|
Clone Cells | 1 | 2010 | 1692 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2085 | 0.020 |
Why?
|
Vaccinia virus | 1 | 2008 | 349 | 0.020 |
Why?
|
Virulence | 1 | 2010 | 1333 | 0.020 |
Why?
|
Tic Disorders | 1 | 2006 | 127 | 0.020 |
Why?
|
HLA Antigens | 1 | 2011 | 1381 | 0.020 |
Why?
|
Diarrhea | 1 | 2013 | 1348 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 2013 | 1678 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2006 | 403 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2065 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2013 | 39050 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2008 | 579 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1692 | 0.020 |
Why?
|
Mucin-1 | 1 | 2010 | 543 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 783 | 0.020 |
Why?
|
Psychology | 1 | 2007 | 356 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13695 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12804 | 0.020 |
Why?
|
Pyrazines | 1 | 2011 | 1230 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2008 | 490 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 2008 | 992 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2234 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1863 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 906 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2010 | 10481 | 0.010 |
Why?
|
New York | 1 | 2006 | 886 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2010 | 1119 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2016 | 3589 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2011 | 1783 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 1222 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3719 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9687 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2010 | 16689 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3768 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9239 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4186 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6038 | 0.010 |
Why?
|
Models, Psychological | 1 | 2007 | 811 | 0.010 |
Why?
|
Gene Silencing | 1 | 2009 | 1538 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2008 | 1000 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13815 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29063 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 2010 | 1023 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3557 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4409 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2011 | 2540 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 2006 | 638 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15519 | 0.010 |
Why?
|
Attitude to Health | 1 | 2011 | 2052 | 0.010 |
Why?
|
Seizures | 1 | 2014 | 2859 | 0.010 |
Why?
|
Health Education | 1 | 2008 | 1056 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2109 | 0.010 |
Why?
|
Cell Cycle | 1 | 2009 | 2967 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4554 | 0.010 |
Why?
|
Age of Onset | 1 | 2006 | 3271 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6756 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3057 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5882 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12026 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2849 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3508 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 20947 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16365 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10397 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2716 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6103 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4253 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5853 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 12720 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9583 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9648 | 0.010 |
Why?
|
Mass Screening | 1 | 2006 | 5255 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 9959 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13102 | 0.000 |
Why?
|